Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC) Meeting Abstract


Authors: Wongchenko, M. J.; Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I.; Andersen, J.; Coelho, J. I. P.; Gil, M. G.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; Singel, S. M.; Maslyar, D. J.; Xu, N.; de la Pena, L.; Baselga, J.; Gendreau, S.; Isakoff, S. J.
Abstract Title: Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC)
Meeting Title: 41st Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 79
Issue: 4 Suppl.
Meeting Dates: 2018 Dec 4-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000478677000438
DOI: 10.1158/1538-7445.Sabcs18-p2-08-19
PROVIDER: wos
Notes: Meeting Abstract: P2-08-19 -- Source: Wos
Altmetric Score
MSK Authors
  1. Jose T Baselga
    438 Baselga